This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitè De Genève. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Margot Boujut - Innovator in Cancer Treatment
Introduction
Margot Boujut is an accomplished inventor based in Bons-en-Chablais, France. She is affiliated with the University of Geneva, where she contributes to innovative research in the field of cancer treatment. Despite having no granted patents to her name, her work is significant in the development of new therapeutic agents.
Latest Patent Applications
Margot Boujut's latest patent application is titled "Adenosine 2A Receptor Modulators for Use in the Treatment of Cancer." This invention relates to new agents that are useful in the treatment of cancers, particularly through immunotherapy. The application also includes pharmaceutically acceptable salts of these agents. Specifically, this invention provides new A2AR modulators, pharmaceutical compositions, and their uses.
Conclusion
Margot Boujut is a promising inventor whose research focuses on innovative solutions for cancer treatment. Her contributions to the field, particularly through her latest patent application, highlight her commitment to advancing medical science.